JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Giles, R. E.
Right arrow Articles by Miller, J. W.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giles, R. E.
Right arrow Articles by Miller, J. W.
Journal of Pharmacology And Experimental Therapeutics, Vol. 156, Issue 2, 201-206, 1967
Copyright © 1967 by American Society for Pharmacology and Experimental Therapeutics


A COMPARISON OF CERTAIN PROPERTIES OF CATECHOL-O-METHYL TRANSFERASE TO THOSE OF ADRENERGIC BETA RECEPTORS

Ralph E. Giles 1 and Jack W. Miller 1

1 Department of Pharmacology, University of Minnesota Medical School, Minneapolis, Minnesota

A series of catecholamines was studied as substrates for liver catechol-O-methyl transferase (COMT) and as agonists for the adrenergic beta receptor in isolated rabbit atria. The rates of methylation of these amines decreased in the order: (highest) protokylol, isoproterenol, N-methylepinephrine, epinephrine and norepinephrine; their order as beta-receptor agonists was: (most potent) isoproterenol, protokylol, epinephrine, norepinephrine and N-methylepinephrine. Concentrations of beta-receptor blocking agents as high as 1 x 10-2 M failed to inhibit COMT in vitro. Pyrogallol and U-0521 (3',4'-dihydroxy-2-methyl-propiophenone) were found to be competitive inhibitors of COMT but possessed no beta-receptor blocking activity on the atria. These findings indicate that COMT cannot serve as a model of the beta receptor.

Submitted on September 2, 1966
Accepted on November 14, 1966







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1967 by the American Society for Pharmacology and Experimental Therapeutics.